Viscosupplementation: a new treatment option for osteoarthritis.

Kathleen A. Geier, Jacob B. Keeperman, Robert C. Sproul, Kevin Roth, H. M. Reynolds

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Osteoarthritis (OA), a degenerative joint disease affecting articular cartilage and synovial joint fluid, is the most common of the rheumatic diseases. OA is a huge public health issue that diminishes the quality of life of millions in the United States. Current treatments for OA include physical therapy, antiinflammatories, narcotics, steroids, and surgery. Unfortunately there is currently no cure for OA and many of the effective treatment modalities have many harsh side effects. Quite recently patients suffering from OA had little alternative to total joint replacement surgery once they exhausted their allotment of steroid injections and started to experience the GI complications associated with traditional NSAIDs. The introduction of viscosupplements, injectable compounds that mimic healthy synovial fluid and often relieve the suffering caused OA, has given patients with OA a longer-term, nonsurgical treatment alternative.

Original languageEnglish
Pages (from-to)25-32
Number of pages8
JournalOrthopaedic nursing / National Association of Orthopaedic Nurses
Issue number5
StatePublished - Sep 1 2002
Externally publishedYes


Dive into the research topics of 'Viscosupplementation: a new treatment option for osteoarthritis.'. Together they form a unique fingerprint.

Cite this